JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
120 hedge funds and large institutions have $2.96B invested in Juno Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
40% less call options, than puts
Call options by funds: $10.2M | Put options by funds: $16.9M
Holders
120
Holding in Top 10
4
Calls
$10.2M
Puts
$16.9M
Top Buyers
| 1 | +$77.8M | |
| 2 | +$72.4M | |
| 3 | +$45.6M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$42M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$24.8M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$18.6M | |
| 3 | -$16.8M | |
| 4 |
DM
Deerfield Management
New York
|
-$10.6M |
| 5 |
Morgan Stanley
New York
|
-$9.03M |